Oppenheimer & Co’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,922
| Closed | -$249K | – | 1664 |
|
|
2024
Q4 | $249K | Sell |
6,922
-19,203
| -74% | -$692K | ﹤0.01% | 1359 |
|
|
2024
Q3 | $1.11M | Buy |
26,125
+20,549
| +369% | +$871K | 0.02% | 762 |
|
|
2024
Q2 | $225K | Sell |
5,576
-2,823
| -34% | -$114K | ﹤0.01% | 1304 |
|
|
2024
Q1 | $297K | Sell |
8,399
-1,400
| -14% | -$49.6K | ﹤0.01% | 1187 |
|
|
2023
Q4 | $290K | Buy |
+9,799
| New | +$290K | 0.01% | 1158 |
|
|
2022
Q4 | – | Sell |
-4,536
| Closed | -$217K | – | 1431 |
|
|
2022
Q3 | $217K | Sell |
4,536
-5,552
| -55% | -$266K | 0.01% | 1195 |
|
|
2022
Q2 | $597K | Buy |
10,088
+2,240
| +29% | +$133K | 0.01% | 855 |
|
|
2022
Q1 | $912K | Buy |
7,848
+2,812
| +56% | +$327K | 0.02% | 777 |
|
|
2021
Q4 | $758K | Sell |
5,036
-1,305
| -21% | -$196K | 0.01% | 888 |
|
|
2021
Q3 | $757K | Sell |
6,341
-2,009
| -24% | -$240K | 0.01% | 843 |
|
|
2021
Q2 | $813K | Buy |
8,350
+2,599
| +45% | +$253K | 0.01% | 830 |
|
|
2021
Q1 | $508K | Buy |
5,751
+312
| +6% | +$27.6K | 0.01% | 957 |
|
|
2020
Q4 | $521K | Sell |
5,439
-3,263
| -37% | -$313K | 0.01% | 869 |
|
|
2020
Q3 | $988K | Sell |
8,702
-914
| -10% | -$104K | 0.02% | 588 |
|
|
2020
Q2 | $952K | Sell |
9,616
-681
| -7% | -$67.4K | 0.02% | 589 |
|
|
2020
Q1 | $662K | Sell |
10,297
-33,093
| -76% | -$2.13M | 0.02% | 647 |
|
|
2019
Q4 | $2.59M | Sell |
43,390
-8,883
| -17% | -$529K | 0.06% | 340 |
|
|
2019
Q3 | $3.08M | Buy |
52,273
+36,804
| +238% | +$2.17M | 0.08% | 268 |
|
|
2019
Q2 | $998K | Sell |
15,469
-31,940
| -67% | -$2.06M | 0.03% | 602 |
|
|
2019
Q1 | $3.01M | Buy |
47,409
+33,453
| +240% | +$2.12M | 0.08% | 286 |
|
|
2018
Q4 | $530K | Buy |
13,956
+7,700
| +123% | +$292K | 0.02% | 710 |
|
|
2018
Q3 | $268K | Buy |
+6,256
| New | +$268K | 0.01% | 1112 |
|
|
2014
Q4 | – | Sell |
-1,630
| Closed | -$219K | – | 1477 |
|
|
2014
Q3 | $219K | Buy |
+1,630
| New | +$219K | 0.01% | 1209 |
|